A new antiretroviral formulation recently given tentative approval from the FDA will make it easier for children with HIV and AIDS in middle- and low-income countries to take life-saving medication.
The formulation combines lopinavir and ritonavir into small oral pellets that can be mixed into a child’s food (http://bit.ly/1KjVyUy). The medication is heat stable and more palatable than currently available medication, making it particularly valuable for treating young children.
Voelker R. Children’s Antiretroviral Combo. JAMA. 2015;314(3):217. doi:10.1001/jama.2015.8143
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: